Nanoscope Therapeutics Inc.
Sarita Chand is an accomplished entrepreneur and investor with a diverse background in finance and technology. As the Founder and CEO of Skills Caravan LXP and the Founder of Indic AI Foundation for social good, Sarita demonstrates a commitment to innovation and social impact. Previously, Sarita co-founded EduPristine and served as a Senior Analyst at Goldman Sachs. Educationally, Sarita holds a degree in Financial Risk Management from Northwestern University's Kellogg School of Management and has completed the Global Association of Risk Professionals (GARP) program.
This person is not in any teams
This person is not in any offices
Nanoscope Therapeutics Inc.
1 followers
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope’s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells. Update: June, 2021: Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa